Ironwood cuts guidance
Ironwood Pharmaceuticals, Inc. revised earnings guidance for its Fiscal Year 2024. Total Revenue reported its Prior 2024 Guidance of $435 to $455 million as compared to Revised 2024 Guidance of revenue to be $405 to $425 million.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.